US PA Philadelphia Falk MJ: Difference between revisions

From Bioblast
No edit summary
No edit summary
Line 10: Line 10:
|state=Pennsylvania (PA)
|state=Pennsylvania (PA)
|country=USA
|country=USA
|weblink=[http://www.med.upenn.edu/apps/faculty/index.php/g275/p8141835 Falk MJ]
|Contact=Falk MJ
|Contact=Falk MJ
|MiPNetLab=Polyak E
|MiPNetLab=Polyak E
|Status=O2k 2008 -
|Status=O2k 2008-
|weblink=[http://www.med.upenn.edu/apps/faculty/index.php/g275/p8141835 Falk MJ]
|keyword=Respiratory OXPHOS disease
|keyword=Respiratory OXPHOS disease
}}
}}

Revision as of 15:30, 26 February 2013

Template:MiPNetLab

  • We use the O2k to study permeabilized human cells and permeabilized mouse tissues to assess integrated respiratory capacity in different genetic mutants and in response to specific pharmacologic agents. Falk MJ

Participated at

  • IOC47
Cookies help us deliver our services. By using our services, you agree to our use of cookies.